810 nm diode grid laser treatment for massive chronic serous retinal detachment following combined kidney and pancreas organ transplantation.
An insulin-dependent diabetic woman of 42 years received a combined pancreas and kidney transplant five years prior to referral to our clinic for ophthalmic consultation. Her systemic immunosupression included oral steroids and she subsequently developed huge bilateral central serous retinal detachments affecting both posterior poles and the temporal midperiphery of the left eye. Her vision was reduced to count fingers (CF) in both eyes. Fluorescein angiography (FA) revealed diffuse mild retinal pigment epithelium (RPE) staining in both eyes. As an empiric treatment grid laser photocoagulation with an 810 nm diode laser (Iridex Corp., Mountain View, California) was performed with complete resorption of subretinal fluid in both eyes and visual improvement to 20/70 in the right eye and 20/200 in the left eye at 18 months post-treatment. In patients diagnosed with atypical central serous retinal detachment whose fluorescein angiogram displays widespread RPE damage and in whom systemic steroids are medically necessary, diode grid laser photocoagulation may be a reasonable treatment option.
Kaplan
Jason
J
University of Pittsburg Eye Center, UPMC Medical Center, Pittsburg, PA 15213, USA.
Friberg
Thomas
T
D001826:Body Fluids; D002908:Chronic Disease; D005122:Exudates and Transudates; D005260:Female; D005451:Fluorescein Angiography; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007429:Intraocular Pressure; D016030:Kidney Transplantation; D017075:Laser Coagulation; D008875:Middle Aged; D016035:Pancreas Transplantation; D011241:Prednisone / Q000009:adverse effects; D012163:Retinal Detachment / Q000139:chemically induced / Q000601:surgery*; D014792:Visual Acuity
D007166:Immunosuppressive Agents; D011241:Prednisone